Education
About Us
Working with TipRanks
Follow Us
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
CRSP Analyst Ratings
Moderate Buy
11 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRSP Stock 12 Month Forecast
Average Price Target
$71.29
▲(16.51% Upside)
| Highest Price Target$105.00 | Average Price Target$71.29 | Lowest Price Target$40.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$55.99→$80
Buy
30.74%
Upside
Reiterated
09/17/25
Bank of America Securities
$78
Buy
27.47%
Upside
Reiterated
09/03/25
Evercore ISI
$99
Buy
61.79%
Upside
Reiterated
08/25/25
Bernstein
―
Hold
―
Reiterated
08/22/25
Truist Financial
$100
Buy
63.43%
Upside
Reiterated
08/08/25
Chardan Capital
$82
Buy
34.01%
Upside
Reiterated
08/05/25
Goldman Sachs
$48
Hold
-21.56%
Downside
Reiterated
08/05/25
William Blair
―
Buy
―
Reiterated
08/05/25
Barclays
$42→$56
Hold
-8.48%
Downside
Reiterated
08/05/25
Needham
$81
Buy
32.37%
Upside
Reiterated
08/05/25
TD Cowen
$35→$40
Hold
-34.63%
Downside
Reiterated
08/05/25
Leerink Partners
$56
Buy
-8.48%
Downside
Reiterated
08/05/25
RBC Capital
$38→$42
Hold
-31.36%
Downside
Reiterated
08/05/25
Citizens JMP
$86
Buy
40.55%
Upside
Reiterated
06/27/25
Piper Sandler
$105
Buy
71.60%
Upside
Reiterated
06/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$55.99→$80
Buy
30.74%
Upside
Reiterated
09/17/25
Bank of America Securities
$78
Buy
27.47%
Upside
Reiterated
09/03/25
Evercore ISI
$99
Buy
61.79%
Upside
Reiterated
08/25/25
Bernstein
―
Hold
―
Reiterated
08/22/25
Truist Financial
$100
Buy
63.43%
Upside
Reiterated
08/08/25
Chardan Capital
$82
Buy
34.01%
Upside
Reiterated
08/05/25
Goldman Sachs
$48
Hold
-21.56%
Downside
Reiterated
08/05/25
William Blair
―
Buy
―
Reiterated
08/05/25
Barclays
$42→$56
Hold
-8.48%
Downside
Reiterated
08/05/25
Needham
$81
Buy
32.37%
Upside
Reiterated
08/05/25
TD Cowen
$35→$40
Hold
-34.63%
Downside
Reiterated
08/05/25
Leerink Partners
$56
Buy
-8.48%
Downside
Reiterated
08/05/25
RBC Capital
$38→$42
Hold
-31.36%
Downside
Reiterated
08/05/25
Citizens JMP
$86
Buy
40.55%
Upside
Reiterated
06/27/25
Piper Sandler
$105
Buy
71.60%
Upside
Reiterated
06/27/25
Best Analysts Covering Crispr Therapeutics AG
1 Month
xxx
Success Rate
11/17 ratings generated profit
Average Return
+8.87%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.71% of your transactions generating a profit, with an average return of +8.87% per trade.
3 Months
xxx
Success Rate
12/21 ratings generated profit
Average Return
+7.99%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +7.99% per trade.
1 Year
Success Rate
11/21 ratings generated profit
Average Return
+8.31%
reiterated a buy rating last month
Copying Mani Foroohar's trades and holding each position for 1 Year would result in 52.38% of your transactions generating a profit, with an average return of +8.31% per trade.
2 Years
xxx
Success Rate
11/21 ratings generated profit
Average Return
+1.59%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 52.38% of your transactions generating a profit, with an average return of +1.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRSP Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
24
30
25
9
2
Buy
5
10
12
12
8
Hold
17
19
21
19
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
46
59
58
40
24
Each month's total comprises the sum of three months' worth of ratings.
CRSP Financial Forecast
CRSP Stock Forecast FAQ
What is CRSP’s average 12-month price target, according to analysts?
Based on analyst ratings, Crispr Therapeutics AG’s 12-month average price target is 71.29.
What is CRSP’s upside potential, based on the analysts’ average price target?
Crispr Therapeutics AG has 16.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRSP a Buy, Sell or Hold?
Crispr Therapeutics AG has a consensus rating of Moderate Buy which is based on 11 buy ratings, 6 hold ratings and 0 sell ratings.
What is Crispr Therapeutics AG’s price target?
The average price target for Crispr Therapeutics AG is 71.29. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $105.00 ,the lowest forecast is $40.00. The average price target represents 16.51% Increase from the current price of $61.19.
The highest analyst price target is $105.00 ,the lowest forecast is $40.00. The average price target represents 16.51% Increase from the current price of $61.19.
What do analysts say about Crispr Therapeutics AG?
Crispr Therapeutics AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of CRSP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.